BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted Orexin and Hypothalamic Neuropeptides for Migraine. Neurotherapeutics 2018;15:377-90. [PMID: 29442286 DOI: 10.1007/s13311-017-0602-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Marichal-Cancino BA, González-Hernández A, Guerrero-Alba R, Medina-Santillán R, Villalón CM. A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications. Expert Rev Neurother 2021;:1-16. [PMID: 34388955 DOI: 10.1080/14737175.2021.1968835] [Reference Citation Analysis]
2 González-hernández A, Condés-lara M, García-boll E, Villalón CM. An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies. Expert Opinion on Drug Metabolism & Toxicology 2021;17:179-99. [DOI: 10.1080/17425255.2021.1856366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bertels Z, Pradhan AAA. Emerging Treatment Targets for Migraine and Other Headaches. Headache 2019;59 Suppl 2:50-65. [PMID: 31291018 DOI: 10.1111/head.13585] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
4 Anderson G. Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin. Curr Pharm Des 2019;25:3550-62. [PMID: 31538885 DOI: 10.2174/1381612825666190920114611] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
5 Di Lorenzo C, Ballerini G, Barbanti P, Bernardini A, D'Arrigo G, Egeo G, Frediani F, Garbo R, Pierangeli G, Prudenzano MP, Rebaudengo N, Semeraro G, Sirianni G, Valente M, Coppola G, Cervenka MC, Spera G. Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations. Nutrients 2021;13:2307. [PMID: 34371817 DOI: 10.3390/nu13072307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Meylakh N, Marciszewski KK, Di Pietro F, Macefield VG, Macey PM, Henderson LA. Altered regional cerebral blood flow and hypothalamic connectivity immediately prior to a migraine headache. Cephalalgia 2020;40:448-60. [PMID: 32164427 DOI: 10.1177/0333102420911623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kristoffersen ES, Børte S, Hagen K, Zwart JA, Winsvold BS. Migraine, obesity and body fat distribution - a population-based study. J Headache Pain 2020;21:97. [PMID: 32762643 DOI: 10.1186/s10194-020-01163-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Pavkovic IM, Kothare SV. Migraine and Sleep in Children: A Bidirectional Relationship. Pediatric Neurology 2020;109:20-7. [DOI: 10.1016/j.pediatrneurol.2019.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris) 2021:S0035-3787(21)00618-4. [PMID: 34325915 DOI: 10.1016/j.neurol.2021.07.007] [Reference Citation Analysis]
10 Zhang Q, Han X, Wu H, Zhang M, Hu G, Dong Z, Yu S. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine. Mol Pain 2019;15:1744806918820452. [PMID: 30799680 DOI: 10.1177/1744806918820452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
11 Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M; School of Advanced Studies of the European Headache Federation (EHF-SAS). Association of diet and headache. J Headache Pain 2019;20:106. [PMID: 31726975 DOI: 10.1186/s10194-019-1057-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
12 Krause DN, Warfvinge K, Haanes KA, Edvinsson L. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP. Nat Rev Neurol 2021;17:621-33. [PMID: 34545218 DOI: 10.1038/s41582-021-00544-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tajti J, Szok D, Nyári A, Vécsei L. Therapeutic strategies that act on the peripheral nervous system in primary headache disorders. Expert Review of Neurotherapeutics 2019;19:509-33. [DOI: 10.1080/14737175.2019.1615447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kooshki R, Abbasnejad M, Esmaeili-mahani S, Raoof M, Sheibani V. Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. Neuropharmacology 2020;178:107981. [DOI: 10.1016/j.neuropharm.2020.107981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Goadsby PJ, Holland PR. Migraine Therapy: Current Approaches and New Horizons. Neurotherapeutics 2018;15:271-3. [PMID: 29667112 DOI: 10.1007/s13311-018-0626-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
16 Mínguez-Olaondo A, Martínez-Valbuena I, Romero S, Frühbeck G, Luquin MR, Martínez-Vila E, Irimia P. Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: a prospective cohort study. J Headache Pain 2020;21:9. [PMID: 32019484 DOI: 10.1186/s10194-020-1082-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Do TP, Al-Saoudi A, Ashina M. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants. Rev Neurol (Paris) 2021:S0035-3787(21)00610-X. [PMID: 34294458 DOI: 10.1016/j.neurol.2021.06.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 González-Hernández A, Marichal-Cancino BA, García-Boll E, Villalón CM. The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms. CNS Neurol Disord Drug Targets 2020;19:344-59. [PMID: 32552657 DOI: 10.2174/1871527319666200618144637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Warfvinge K, Krause DN, Maddahi A, Grell AS, Edvinsson JC, Haanes KA, Edvinsson L. Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors. Cephalalgia 2020;40:1283-95. [PMID: 32486908 DOI: 10.1177/0333102420929027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
20 Chen Z, Chen X, Liu M, Ma L, Yu S. Volume of Hypothalamus as a Diagnostic Biomarker of Chronic Migraine. Front Neurol 2019;10:606. [PMID: 31244765 DOI: 10.3389/fneur.2019.00606] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
21 Subramanian S, Ravichandran M. Orexin receptors: Targets and applications. Fundam Clin Pharmacol 2021. [PMID: 34464995 DOI: 10.1111/fcp.12723] [Reference Citation Analysis]
22 Boström A, Scheele D, Stoffel-Wagner B, Hönig F, Chaudhry SR, Muhammad S, Hurlemann R, Krauss JK, Lendvai IS, Chakravarthy KV, Kinfe TM. Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study. J Transl Med 2019;17:53. [PMID: 30795781 DOI: 10.1186/s12967-019-1801-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
23 Kinfe TM, Buchfelder M, Chaudhry SR, Chakravarthy KV, Deer TR, Russo M, Georgius P, Hurlemann R, Rasheed M, Muhammad S, Yearwood TL. Leptin and Associated Mediators of Immunometabolic Signaling: Novel Molecular Outcome Measures for Neurostimulation to Treat Chronic Pain. Int J Mol Sci 2019;20:E4737. [PMID: 31554241 DOI: 10.3390/ijms20194737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]